Journal

DR.INFO offers an evidence-first medical AI API. This reflects a wider shift from standalone medical chatbots to clinical information infrastructure.

DR.INFO is a CE-marked medical AI assistant, but its own label says outputs must be independently reviewed. Here is how doctors should read medical AI safety claims.

DR.INFO, Praxis Medicine, OpenEvidence, and iatroX show that clinical AI search is becoming a serious category across Europe and the UK.

DR.INFO includes visual abstracts that turn complex studies into teaching visuals. Here is why visual medical AI may matter for clinical education — and why active recall still mat...

DR.INFO's CE-marked positioning shows how European clinical AI is moving toward regulation, source references, and professional-use boundaries.

DR.INFO is a European AI medical assistant offering cited answers, drug search, clinical guideline search, and visual abstracts. Here is what doctors should know before using it.

Looking for an alternative to DR.INFO? This guide compares iatroX, OpenEvidence, Praxis Medicine, Medwise, AMBOSS AI Mode and other medical AI tools for UK clinicians.

Clinical AI search will not be won by the chatbot that sounds most confident. It will be won by the system that can show its sources, understand local practice, sit inside the clin...

The European clinical AI search market mapped: Praxis, Medwise, AMBOSS AI Mode, ClariMed, Umbil, iatroX, and UpToDate Expert AI. Geography, guideline localisation, and workflow int...

Praxis Medicine is not important because Europe needs another AI chatbot. It is important because it shows that clinical evidence retrieval — finding, summarising and citing the ri...

OpenEvidence has withdrawn from the UK and EU, citing regulatory uncertainty around the EU AI Act. For the 40%+ of US physicians who use it daily, this changes nothing. For Europea...

The clinical AI war of 2026: OpenEvidence ($12B, ad-funded, Epic-embedded) vs UpToDate ($500/yr, expert-curated, 30-year incumbent) vs DoxGPT (PeerCheck-verified, 85% of US doctors...